author-photo

Antonio Mulè

5

Papers

11

Citations

Citation Trend

Filter By

Papers (5) Sort By

Journal Conference Others

Randomized Trial Comparing R-chop-14 Versus High Dose Sequential Chemotherapy in High Risk Patients with Diffuse Large B-cell Lymphomas. Final results from the Gitil-rhds0305 study: O064

2016 Bone Marrow Transplantation
Show All
- Source
- Cite
- Save
Citations (0)
Results of a randomized trial comparing high-dose chemotherapy plus Auto-SCT and R-FC in CLL at diagnosis

2014 Bone Marrow Transplantation
Show All
- Source
- Cite
- Save
Citations (9)
Feasibility and efficacy of high doses of antimetabolites followed by high-dose sequential chemoimmunotherapy (R-HDS) and autologous stem cell transplant (ASCT) in patients (pts) with systemic B-cell lymphoma (BCL) and central nervous system (CNS) involvement: A multicenter phase II trial.

2014 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
High-dose sequential chemotherapy and rituximab (R-HDS) supported by autologous stem cell transplantation (ASCT) in patients (pts) with systemic B-cell lymphoma with CNS involvement (SCNSL) at diagnosis or relapse: Interim analysis of feasibility and activity of a phase II trial.

2010 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Male Gender, Quality of Grafted Cells, Advanced Age, Rituximab and Radiotherapy Are the Main Factors That Variously Influence the Occurrence of Secondary Malignancies Following High-Dose Therapy and Autograft: A GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) Survey in 1,347 Lymphoma Patients.

2009 Blood
Show All
- Source
- Cite
- Save
Citations (1)